Jeremy A. Tigan
View All Practices
Jeremy is an IP litigation partner. He serves as Practice Group Coordinator of Morris Nichols’ Intellectual Property Litigation Group.
Jeremy’s practice focuses on patent infringement disputes before the Delaware District Court. Acting as lead or Delaware counsel to clients from a variety of industries, his work tends to concentrate on pharmaceuticals, software, and networking technology.
His significant experience includes bench and jury trials, appeals, and virtual proceedings in patent and trademark cases.
He has been ranked as a leading Delaware patent litigator by various research publications, including Chambers USA, IAM Patent 1000, Managing Intellectual Property’s IP Stars, The Best Lawyers in America, and Delaware Super Lawyers.
Jeremy is immediate past-president of the Delaware Chapter of the Federal Bar Association and has led the organizing committee for the biannual District of Delaware Bench & Bar Conference.
Experience
CyDex Pharmaceuticals, Inc. v. Lupin Limited et al, C.A. No. 19-02043 (D. Del.); CyDex Pharmaceuticals, Inc. v. Alembic Global Holding SA et al, C.A. No. 19-00956 (D. Del.); CyDex Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. et al, C.A. No. 17- 01832 (D. Del.)
Pharmacyclics LLC, et al. v. Cipla Ltd., et al., C.A. No. 18-192 (D. Del.)
Roche Diagnostics Corporation v. Meso Scale Diagnostics, LLC, C.A. No. 17-189 (D. Del.)
Liqwd, Inc. et al v. L'Oreal USA, Inc. et al., C.A. No. 17-14 (D. Del.)
Galderma Laboratories LP et al v. Teva Pharmaceuticals U.S.A., Inc., C.A. No. 17-1783 (D. Del.)
Integra LifeSciences Corp., et al. v. HyperBranch Medical Technology, Inc., C.A. No. 15-819 (D. Del.)
Recro Gainesville LLC v. Actavis Laboratories FL, Inc., C.A. No. 14-1118 (D. Del.); Recro Gainesville LLC v. Alvogen Malta Operations Ltd., C.A. No. 14-1364 (D. Del.); Recro Gainesville LLC v. Actavis Laboratories FL, Inc., Fed. Cir., No. 17-1822
Superior Oil Co. v. Solenis Technologies L.P., C.A. No. 15-183-GMS (D. Del.); Buckman Laboratories, Inc. v. Solenis, LLC, C.A. No. 2:15-cv-2063-JPM-tmp (W.D. Tenn.); Hydrite Chemical Co. v. Solenis Technologies LP, C.A. No. 2:15-cv-00856 (E.D. Wisc.)
Cadence Pharms., Inc., SCR Pharmatop, & Mallinckrodt IP v. InnoPharma Licensing LLC & InnoPharma Inc., C.A. No. 14-1225 (D. Del.); Cadence Pharms, Inc., SCR Pharmatop, & Maillinckrodt IP v. Agila Specialties Inc. & Mylan Labs., Ltd., C.A. No. 14-1499 (D. Del.)
Butamax Advanced Biofuels LLC v. Gevo Inc., C.A. No. 11-054-SLR (D. Del.) (Phase I case)
News & Insights
Speaking Engagement, 09.21.2023 through 09.22.2023Sophie Rogers Churchill will moderate the panel, “Bankruptcy: Evolution of DIP Financing Orders.”
Honors & Recognitions
Chambers USA: America’s Leading Lawyers for Business, ranked in Delaware for intellectual property, since 2020
IAM Patent 1000: The World’s Leading Patent Practitioners, silver-ranked among leading Delaware patent professionals, since 2019
Managing Intellectual Property, IP Star, since 2021
The Best Lawyers in America, listed in Delaware litigation-intellectual property, since 2021
Delaware Super Lawyers, recognized by his peers as an intellectual property litigation “Rising Star,” 2018
Professional & Civic
American Bar Association
American Intellectual Property Law Association
Delaware State Bar Association
Federal Bar Association Delaware Chapter (past-president)
Federal Civil Panel
Federal Circuit Bar Association
Education
George Mason University School of Law, JD, cum laude, 2007
Moot Court Board
National Moot Court Competition Team
2013 Federal Trial Practice Seminar, sponsored by the US District Court for the District of Delaware and the Federal Bar Association
The George Washington University, MA, political science, with distinction, 2004
University of Oregon, BS, political science, 2002
Admissions
- Delaware, 2008
- US District Court for the District of Delaware, 2009
- US Court of Appeals for the Third Circuit, 2013
- US Court of Appeals for the Federal Circuit, 2011